Global Telmisartan Market: Overview

A study shows that the disease burden of hypertension shot up from 87 million in 2000 to little more than 108 million in 2016. Not just that, the average age of a person affected by the condition also dropped from 48.4 to 45.4 during this period. This is a serious indication of how more people, with every year, are falling prey to this lifestyle disease. This, as a result, expands opportunities for drugs to treat hypertension, and one of the prominent brands in the market is Telmisartan.

As of now, the global telmisartan market holds a significant position in the market when compared to other competitors. An upcoming Transparency Market Research (TMR) report elucidates on every aspect critical for growth in the global market for telmisartan. The report’s details like key trends, challenges, opportunities, geographical analysis, and competitive dynamics are key for both existing and upcoming players.

Global Telmisartan Market: Notable Developments

Patented in 1991 and brought into the market in 1999, the generic drug has come a long way since then. Some of the recent developments in the global telmisartan market are:

  • In 2017, leading pharmaceutical company Zydus Cadila received permissions to sell its version of temisartan and hydrocholothiazide tablets. The drug brought into the market in three different dosages.
  • Mylan Inc. launched three versions of Telmisartan in July 2014 which is a generic from Boehringer Inglheim. It received approval from the US Food and Drug Administration.

Other than these developments, almost every player in the global telmisartan market is keen on investing in developing better versions of the existing drug. Further, the evolving population and changing needs of practitioners is also opening doors for new opportunities. Some of the prominent brands in the global market for telmisartan are General Electric Company, Neurovision Medical Products, Medtronic Plc., C. R. Bard Inc., Smith Medical, Inc., ConvaTec Group Plc., Royax, KindWell Medical Equipment Co.,Ltd, Teleflex Incorporated., Fuji Systems Corp., and Intersurgical GmbH.

Global Telmisartan Market: Key Trends

Spike in Lifestyle Diseases to Favor Consumption

The common term associated with lifestyle today is sedentary. Given the high-pressure work life, and air-conditioned work environments of corporates, the need for people to stay active has reduced drastically. All these aspects collectively instill lifestyle diseases like diabetes, hypertension, and cardiovascular diseases. While lack of activity will increase the chances of the disease, the rising population adapting to smoking and alcohol to destress is expected to spike the incidence of cardiovascular diseases. Telmisartan is used to treat all of these above conditions. With the number of patients increasing, consumption in the global telmisartan market is only expected to increase in the coming years.

Rise in Cases of Chronic Kidney Disease

About 14% of the world’s population is affected by chronic kidney disease, and research studies show that diabetes and hypertension are the two prime reasons for it. Having said that, telmisartan, has been proven efficient in treating diabetic kidney disease. Studies indicate that the percentage of people suffering from chronic kidney disease will inflate in the coming years, thus spiking demand for telmisartan.

Global Telmisartan Market: Geographical Analysis

Looking at the diseases that telmisartan treats, the market for this drugs is spread across all territories. Based on existing trends and predictions of TMR, North America is expected to hold the highest share in terms of revenue in the global telmisartan market. The rising hypertension and diabetic population in this region, and highly aware consumer base will sustain demand here. Further, Asia Pacific is predicted to emerge in the coming years as a significant proportion of the affected patient population hails from countries here. Also, the growing prominence of the pharmaceutical sector in this part of the world will stimulate demand for telmisartan zin the coming years.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Telmisartan Market

Pre Book